A recent report showed that ROS restriction by TIGAR supports premalignant tumor initiation while restricting metastasis in pancreatic ductal adenocarcinoma, indicating that the complexity of ROS regulation underpins full malignant progression [29]. Here, TIGAR is linked to pancreatic ductal adenocarcinoma.